Example: Heart Attack

Search clinical trials for: Bone Density Conservation Agents

Total 3113 results

NCT01321723

Completed

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Conditions: Postmenopausal Osteoporosis
NCT02325414

Completed

Prevention of Bone Loss After Acute SCI by Zoledronic Acid

Conditions: Spinal Cord Injury; Acute Spinal Cord Injury; Bone Loss; Osteoporosis
NCT01345019

Completed

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Conditions: Cancer; Hematologic Malignancies; Multiple Myeloma; Oncology; Bone Metastases; Multiple Myeloma Bone Lesions
NCT04549207

Not yet recruiting

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Conditions: Breast Cancer; Castration-resistant Prostate Cancer
NCT02721433

Active, not recruiting

4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases

Conditions: Breast Cancer; Prostate Cancer; Metastasis
NCT04232657

Not yet recruiting

Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

Conditions: Spinal Cord Injury (=3 Years); Sublesional Bone Loss Secondary to SCI
NCT03960554

Recruiting

The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients

Conditions: Osteoporosis; Renal Osteodystrophy; Kidney Transplant; Complications
NCT02499237

Completed

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation

Conditions: Postmenopausal Osteoporosis
NCT04366726

Completed

Study to Evaluate the PK, PD and Usability of Abaloparatide-sMTS in Postmenopausal Women With Low Bone Mineral Density

Conditions: Postmenopausal Osteoporosis
NCT01812551

Completed

Treatment of Low Bone Density in Cystic Fibrosis.

Conditions: Osteoporosis; Cystic Fibrosis
NCT04034199

Not yet recruiting

Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid

Conditions: Idiopathic Inflammatory Myopathies; Osteoporosis, Osteopenia
NCT00213980

Completed

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Conditions: Breast Cancer
NCT00202059

Completed

Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer

Conditions: Breast Cancer
NCT00887965

Completed

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

Conditions: Low Bone Mass; Low Bone Mineral Density; Osteoporosis; Postmenopausal Osteoporosis
NCT00261625

Completed

Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?

Conditions: End-Stage Renal Disease; Osteoporosis
NCT03292146

Active, not recruiting

Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study

Conditions: Bone Density; Bone Loss; Anorexia Nervosa; Eating Disorder; Atypical Anorexia Nervosa
NCT01770106

Completed

RA Denosumab on Bone Microstructure Study

Conditions: Rheumatoid Arthritis
NCT01889134

Completed

OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

Conditions: Primary Hyperparathyroidism
NCT00325468

Completed

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

Conditions: Low Bone Mineral Density
NCT00114556

Completed

The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

Conditions: Osteoporosis; Liver Transplantation; Fractures
NCT02025179

Completed

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

Conditions: Spinal Cord Injury; Bone Loss; Osteoporosis
NCT01287533

Completed

Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids

Conditions: Rheumatoid Arthritis; Osteoporosis; Osteopenia
NCT00035997

Completed

Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis

Conditions: Prostate Cancer
NCT01572545

Completed

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

Conditions: Postmenopausal Osteoporosis
NCT04140006

Enrolling by invitation

Efficacy of Antiresorptive and Bone Forming Material on Dental Implants

Conditions: Partial Edentulism